Articles tagged "Outcome"

2019 American Transplant Congress
Recipients with Model for End-Stage Liver Disease Sodium Score Driven by Renal Dysfunction Have Increased Post-Transplant Mortality
T. Bittermann, D. Goldberg
Gastroenterology, University of Pennsylvania, Philadelphia, PA
*Purpose: Since the adoption of the Model for End-stage Liver Disease (MELD) score as a primary means of waitlist prioritization for liver transplantation (LT), an…
2019 American Transplant Congress
Urine Uromodulin Associates with Deceased Donor Acute Kidney Injury and Allograft Failure
S. G. Mansour¹, I. Hall², P. Reese³, T. Ashkar⁴, Y. Jia⁴, H. Thiessen-Philbrook⁴, M. Doshi⁵, C. R. Parikh⁴
¹Yale, New Haven, CT, ²University of Utah, Salt Lake City, UT, ³Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, ⁴Johns Hopkins University, Baltimore, MD, ⁵University of Michigan, Ann Arbor, MI
*Purpose: Produced exclusively by renal epithelial cells of the thick ascending limb, Uromodulin (UMOD, also known as Tamm-Horsfall protein) is the major component of hyaline…
2019 American Transplant Congress
Impact of a Novel Digital Medicine Program on Adherence and Utilization in Pediatric Transplant Patients
S. Sullivan¹, K. N. Triplett¹, C. Sacks², M. Tran², D. M. Desai³
¹Solid Organ Transplant, Children's Medical Center, Dallas, Dallas, TX, ²Proteus Digital Health, Redwood City, CA, ³Transplant Surgery, University of Texas Southwestern Medical Center at Dallas, Dallas, TX
*Purpose: Purpose: Optimal allograft function and long-term graft survival depends on many factors, including adherence to a complex medication regimen. Methods of measuring adherence are…
2019 American Transplant Congress
Type of Induction Does Not Impact Patient or Kidney Allograft Survival in Simultaneous Liver and Kidney Transplant Recipients in the United States
S. Riad¹, N. Lim², S. Jackson³, J. Lake²
¹University of Minnesota, Minneapolis, MN, ²Medicine, University of Minnesota, Minneapolis, MN, ³Complex Care Analytics, Fairview Health Services, Minneapolis, MN
*Purpose: Induction practices vary widely in the United States for patients undergoing simultaneous liver and kidney (SLK) transplantation. We examined the impact of induction type…
2019 American Transplant Congress
Multidisciplinary Practitioner Perspectives on Cardiovascular Disease Guideline Interventions in Liver Transplant Recipients
M. Kosirog¹, L. Adamski¹, A. Daud², D. Finn², D. Gregory¹, D. M. Lloyd-Jones³, J. L. Holl⁴, L. B. VanWagner⁵
¹Medicine-GI & Hepatology, Northwestern University, Chicago, IL, ²Center for Healthcare Studies, Northwestern University, Chicago, IL, ³Medicine-Cardiology and Preventive Medicine, Northwestern University, Chicago, IL, ⁴Pediatrics & Center for Healthcare Studies, Northwestern University, Chicago, IL, ⁵Medicine-GI & Hepatology and Preventive Medicine, Northwestern University, Chicago, IL
*Purpose: Cardiovascular disease (CVD) is a leading cause of mortality in liver transplant recipients (LTRs). However, there is a lack of LT-specific CVD clinical practice…
2019 American Transplant Congress
A Retrospective Matched Case-Control Study of Medical and Psychiatric Outcomes in Kidney Transplant Recipients with Bipolar Disorder
A. GOSWAMI BANERJEE¹, S. Hamel², R. Weinrieb¹, S. Dave¹, V. Johnson³, D. Sawinski⁴, J. Trofe-Clark³
¹Psychiatry, Univ. of Pennsylvania, Philadelphia, PA, ²Vanderbilt Univ. Medical Center, Nashville, TN, ³Pharmacy, Hospital of the Univ. of Pennsylvania, Philadelphia, PA, ⁴Renal, Univ. of Pennsylvania, Philadelphia, PA
*Purpose: Management of kidney transplant recipients (KTRs) with bipolar disorder (BD) is complicated by risk factors for non-adherence, complex medication regimens and limited published guidance.…
2019 American Transplant Congress
Liver Transplantation in Acute Hepatic Insufficiency Induced by Imatinib
A. I. David¹, D. N. Alvarenga de Rezende², M. C. Fantauzzi³, T. Di Santi³, N. C. Confuorto³, G. T. Martinho³, P. S. Antunes³
¹GI Surgery/Transplant, Hospital Samaritano de Sao Paulo, Sao Paulo, Brazil, ²GI Surgery/Transplant, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Sao Paulo, Brazil, ³Faculdade de Ciências Médicas da Santa Casa de São Paulo, Sao Paulo, Brazil
*Purpose: Case report of a Woman, pediatrician, 40 yo,with chronic myeloid leukemia using Imatinib who developed Serious Acute Hepatic Failure and needed liver transplant to…
2019 American Transplant Congress
Build It, They Will Come: Surgical Renal Outpatient Infusion Room Decreases Readmission Rates
J. Truckenbrod¹, K. DeWall¹, M. Jones¹, E. VanLith¹, M. Anderson¹, L. Jaeger¹, M. Phillips², W. Kendall¹, L. Burris¹, T. Thambi¹
¹Transplant, Sanford USD Medical Center and Hospital, Sioux Falls, SD, ²Surgical Renal, Sanford USD Medical Center and Hospital, Sioux Falls, SD
*Purpose: Post-renal transplant patients present a unique set of complex medical concerns that are best served by qualified, transplant-trained healthcare professionals. Post-renal transplant patients often…
2019 American Transplant Congress
Evaluating Hepatitis C Treatment after Solid Organ Transplantation
A. J. Burgos¹, R. Yau¹, C. Tunwar², J. A. Goss³, S. Khaderi³, N. L. Sussman⁴
¹Pharmacy, CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston, TX, ²CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston, TX, ³Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, ⁴Abdominal Transplant & Liver Disease, Baylor College of Medicine, Houston, TX
*Purpose: There is limited data on the use of direct acting antivirals for hepatitis C virus (HCV) in the solid organ transplant (SOT) population. The…
2019 American Transplant Congress
Breaking Concepts: 10-year Follow-Up of the Everolimus versus Azathioprine Heart Transplant Multi-National Study
J. A. Kobashigawa¹, R. Starling², E. Passano¹, P. Bernhardt³, B. Azarbal¹, R. Cheng¹, F. Esmailian¹, K. Khush⁴, D. Mancini⁵, J. Patel¹, T. Sato¹, S. Varnous⁶
¹Smidt Heart Institute at Cedars-Sinai, Los Angeles, CA, ²Cleveland Clinic, Cleveland, OH, ³Novartis Pharmaceuticals, Basel, Switzerland, ⁴Stanford University, Palo Alto, CA, ⁵Mount Sinai, New York, NY, ⁶APHP, Pitié‐Salpétrière, Sorbonne University, Paris, France
*Purpose: This study is the 10-year follow-up of a randomized double-blind prospective trial that compared everolimus (1.5 mg or 3 mg) to azathioprine. In this…